Substance

ID:349101

Sildenafil citrate salt

Names and Identifiers
IUPAC Traditional name
citro; sildenafil
Synonyms
Revatio 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate saltUK-92,480Sildenafil citrate salt5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt
IUPAC name
2-hydroxypropane-1,2,3-tricarboxylic acid; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one
Registration numbers
CAS Number
MDL Number
Properties
Safety Information
GHS Hazard statements
H315-H319-H335
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
European Hazard Symbols
Irritant Irritant (Xi)
GHS Precautionary statements
P261-P305+P351+P338
MSDS Link
German water hazard class
3
GHS Signal Word
Warning
Risk Statements
36/37/38
Storage Temperature
room temp
Safety Statements
36
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C22H30N6O4S ·C6H8O7
Physical Property
Solubility
DMSO: >20 mg/mL
Apperance
white powder
Molecule Details
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Sildenafil is a potent, selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5). Sildenafil is used to treat erectile dysfunction and pulmonary arterial hypertension. NO activates guanylate cyclase, which results in increased levels of cGMP, producing smooth muscle relaxation. Sildenafil enhances the effect of NO by inhibiting PDE5, which is responsible for degradation of cGMP.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data